脑部放疗，上午比下午敏感许多！* A7 W* |( R8 [; w+ g
; \# q2 `5 O3 P+ U! N/ O$ |$ P6 m# _# z1 q
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.: Z; P* Y' y$ t
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
K0 {4 Q% F: s7 z7 F: q) qRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.! @; S* Q$ l0 V! C- n/ L- ~* h
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.. E' N. n) U' j Y) Y
( H# N: E( r, |' [9 ^Abstract0 U {; Q9 d u6 [' i8 |9 S
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.+ P: E4 a( S k7 _8 t- z& e* _
4 i; F; S: ~+ x9 s3 ?7 YMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic., C2 W8 F$ ]5 O, j. F9 P) q( r
: A# P! V b4 _! _# t6 dRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
2 w( X, A8 U# ~: G/ W2 M7 |$ B: E, \( L
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.% c) v# |1 l" h; Z7 U
6 R" Y) [/ }- w, Z1 m# Y |
! X! ^+ D7 o% o9 o5 [( c
显身卡
